Skip to main content

FDA Updates

FDA Updates

FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management

Jerm Day-Storms, PhD, MWC

FDA Updates

Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma

FDA Updates

Welireg Now FDA Approved for Patients with Advanced Renal Cell Carcinoma

FDA Updates

Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of Advanced Gastroesophageal Junction Adenocarcinoma

FDA Updates

FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Adults With Metastatic or Recurrent Nasopharyngeal Carcinoma

FDA Updates

Tibsovo FDA Approved for Patients With Relapsed Myelodysplastic Syndromes and IDH1 Mutation

FDA Updates

Pylarify Second Radioactive Imaging Drug FDA Approved for PSMA-Positive Prostate Cancer

FDA Updates

FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma

FDA Updates

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

FDA Updates

Pembrolizumab plus Lenvatinib Combination Receives Regular Approval for Advanced Endometrial Carcinoma

1
2
3
4

Page 1 of 13
Results 1 - 10 of 123